![Canada - Antisera And Other Blood Fractions - Market Analysis, Forecast, Size, Trends and Insights](/landing/img/reports/canada-antisera-and-other-blood-fractions-market-analysis-forecast-size-trends-and-insights.webp)
Canada - Antisera And Other Blood Fractions - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingAntisera Price in Canada - 2023
Contents:
- Antisera Price in Canada (CIF) - 2022
- Antisera Price in Canada (FOB) - 2022
- Antisera Imports in Canada
- Antisera Exports in Canada
Antisera Price in Canada (CIF) - 2022
The average antisera import price stood at $145,948 per ton in 2022, declining by -23.2% against the previous year. Overall, the import price, however, posted a pronounced expansion. The pace of growth was the most pronounced in 2016 an increase of 51% against the previous year. The import price peaked at $273,942 per ton in 2019; however, from 2020 to 2022, import prices failed to regain momentum.
Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Switzerland ($958,220 per ton), while the price for Poland ($5,517 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Switzerland (+19.0%), while the prices for the other major suppliers experienced more modest paces of growth.
Antisera Price in Canada (FOB) - 2022
The average antisera export price stood at $21,052 per ton in 2022, surging by 21% against the previous year. Over the period from 2012 to 2022, it increased at an average annual rate of +2.1%. The most prominent rate of growth was recorded in 2019 when the average export price increased by 27%. As a result, the export price reached the peak level of $26,788 per ton. From 2020 to 2022, the average export prices remained at a lower figure.
Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Turkey ($36,532 per ton), while the average price for exports to Germany ($7,378 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Singapore (+26.5%), while the prices for the other major destinations experienced more modest paces of growth.
Antisera Imports in Canada
For the fourth year in a row, Canada recorded growth in overseas purchases of antisera and other blood fractions, which increased by 38% to 35K tons in 2022. In general, imports posted a significant expansion. The pace of growth was the most pronounced in 2020 when imports increased by 44%. Over the period under review, imports reached the peak figure in 2022 and are likely to continue growth in years to come.
In value terms, antisera imports rose rapidly to $5.1B in 2022. The total import value increased at an average annual rate of +10.4% from 2019 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2021 when imports increased by 17% against the previous year. Imports peaked in 2022 and are likely to see gradual growth in the immediate term.
Import of Antisera in Canada (Million USD) | |||||
---|---|---|---|---|---|
COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
United States | 1,181 | 1,348 | 1,285 | 1,407 | 6.0% |
Switzerland | 906 | 1,011 | 1,052 | 920 | 0.5% |
Germany | 953 | 976 | 1,071 | 820 | -4.9% |
South Korea | 25.1 | 82.7 | 308 | 632 | 193.1% |
Ireland | 161 | 118 | 271 | 247 | 15.3% |
Japan | 43.1 | 37.2 | 125 | 202 | 67.3% |
Belgium | 156 | 172 | 196 | 200 | 8.6% |
China | 11.8 | 20.0 | 33.7 | 140 | 128.1% |
Austria | 106 | 109 | 131 | 100 | -1.9% |
France | 57.0 | 50.4 | 83.5 | 87.6 | 15.4% |
Sweden | 3.3 | 7.7 | 19.9 | 32.0 | 113.2% |
Australia | 1.4 | 2.4 | 0.8 | 11.0 | 98.8% |
Poland | N/A | N/A | N/A | 3.2 | 0% |
Others | 156 | 131 | 188 | 267 | 19.6% |
Total | 3,761 | 4,066 | 4,765 | 5,068 | 10.5% |
Top Suppliers of Antisera to Canada in 2022:
- United States (14.5K tons)
- South Korea (5.4K tons)
- Austria (2.9K tons)
- Germany (2.7K tons)
- Japan (1.2K tons)
- Australia (1.1K tons)
- China (1.1K tons)
- Switzerland (1.0K tons)
- Sweden (0.7K tons)
- Belgium (0.7K tons)
- Poland (0.6K tons)
- Ireland (0.6K tons)
- France (0.4K tons)
Antisera Exports in Canada
After three years of growth, overseas shipments of antisera and other blood fractions decreased by -6.6% to 12K tons in 2022. Overall, exports, however, enjoyed significant growth. The growth pace was the most rapid in 2021 when exports increased by 105% against the previous year. As a result, the exports attained the peak of 13K tons, and then declined in the following year.
In value terms, antisera exports rose remarkably to $255M in 2022. Over the period under review, exports, however, continue to indicate a remarkable increase. The growth pace was the most rapid in 2021 with an increase of 78%. Over the period under review, the exports attained the peak figure in 2022 and are expected to retain growth in the immediate term.
Export of Antisera in Canada (Million USD) | |||||
---|---|---|---|---|---|
COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
United States | 112 | 87.2 | 159 | 192 | 19.7% |
Germany | 11.7 | 13.8 | 30.5 | 14.3 | 6.9% |
Brazil | 0.1 | 0.1 | 0.2 | 5.8 | 287.1% |
Vietnam | 2.1 | 3.8 | 4.2 | 5.6 | 38.7% |
South Korea | 5.7 | 1.5 | 4.7 | 4.6 | -6.9% |
Others | 23.5 | 20.5 | 28.2 | 33.0 | 12.0% |
Total | 156 | 127 | 226 | 255 | 17.8% |
Top Export Markets for Antisera from Canada in 2022:
- United States (8.6K tons)
- Germany (1.9K tons)
- Brazil (0.3K tons)
- Vietnam (0.3K tons)
- South Korea (0.2K tons)
This report provides an in-depth analysis of the antisera market in Canada. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21202125 - Antisera, other immunological products which are directly involved in the regulation of immunological processes and other blood fractions
Country coverage:
- Canada
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Canada
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
This report provides an in-depth analysis of the antisera market in Canada.
This report provides an in-depth analysis of the biological product market in Canada.
This report provides an in-depth analysis of the vaccine market in Canada.
This report provides an in-depth analysis of the market for human and animal blood in Canada.
This report provides an in-depth analysis of the veterinary medicine vaccines market in Canada.
This report provides an in-depth analysis of the global antisera market.
This report provides an in-depth analysis of the global biological product market.
This report provides an in-depth analysis of the global vaccine market.
This report provides an in-depth analysis of the global market for human and animal blood.
This report provides an in-depth analysis of the global veterinary medicine vaccines market.
Imports of Vaccines peaked at 3.3K tons in 2022, only to contract in the following year. The value of vaccine imports also decreased to $3.1B in 2023.
From 2022 to 2023, the growth of imports in the Human And Animal Blood sector failed to regain momentum. In value terms, imports sharply declined to $263M in 2023.
The article provides insights into the anticipated growth of the global market for antisera and other blood fractions over the next seven years, driven by increasing demand. Market performance is forecasted to expand with a CAGR of +1.7% in volume terms and +6.5% in value terms, reaching 707K tons and $580.4B respectively by the end of 2030.
Explore the top import markets for antisera and their key statistics. Find out which countries dominate the global import market for antisera and their import values.
Global trade in antisera and other blood fractions reached the highest level ever, totalling near $182B in 2020. The U.S., Germany, China, Spain, the UK and South Korea top the world’s largest antisera exporter ranking, comprising 67% of the total shipments. More than half of antisera imports are supplied to Germany, the U.S., Austria, Spain, Italy, China and Switzerland.
In 2016, the antisera and other blood fractions market grew by X% to X billion USD. From 2007 to 2016, the global value of consumption of antisera and other blood fractions almost doubled, which was due to the rising demand in developing countries.
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
From 2007 to 2015, global exports of antisera and other blood fractions showed steady growth, amounting to X million USD in 2015. There was an annual increase of +X% throughout the analyzed period.
Switzerland seized control of the antisera and other blood fractions market. In 2014, Switzerland exported X thousand tons of antisera and other blood fractions totaling X billion USD, X% over the previous year. Its primary trading partner was G